Biotech

All Articles

Cullinan, after $25M package, return bispecific to Harbour

.Cullinan Therapy was impressed good enough with Port BioMed's bispecific immune activator that it h...

A nearer take a look at Brutal Biotech's Brutal 15

.In this full week's episode of "The Best Pipe," our experts're diving into Brutal Biotech's annual ...

Lilly deals with phase 2 failure of tau-targeting med

.The confetti is actually still flying from Eli Lilly's event celebrating the approval of Alzheimer'...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings...

Lykos are going to ask FDA to rethink its choice complying with turndown of MDMA therapy for trauma

.Adhering to an unsatisfactory presenting for Lykos Rehabs' MDMA applicant for post-traumatic stress...

AN 2 one-halfs headcount, ceases period 3 test after records dissatisfy

.AN2 Rehabs is actually reassessing its own organization in response to poor midphase information, s...

Merck pays out $700M for bispecific, spying autoimmune position as well as possibility to challenge Amgen in cancer cells

.Merck &amp Co. is spending $700 thousand in advance to test Amgen in a blood stream cancer cells ma...

Gilead pays for J&ampJ $320M to leave licensing bargain for seladelpar

.Along With Gilead Sciences almost an FDA decision for its own liver health condition drug seladelpa...

' All hands on deck' at Lilly as peers target being overweight market

.Chief executive officer David Ricks may find the business establishing tents at basecamp behind Eli...

Entero giving up staff, leaving office and also stopping R&ampD

.Mattress Liquidators has actually transformed Entero Therapies white as a slab. The financial insti...